This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 100S. The contract has a firm fixed price of $34,204.00 and an ultimate completion date of August 13, 2024. AmerisourceBergen is the prime contractor, and there is no set-aside designation mentioned. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,651.91 firm-fixed-price delivery order contract is for the supply of 4,568,039,684 units of CELLCEPT 500 MG TABLET 500S, a medication used for organ transplant patients. The contract has an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at $9,377.75, is for the delivery of 4564312523 - CELLCEPT 500 MG TABLET 100S, a prescription medication. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 100S, a prescription medication, with a ceiling value of $15,853.96 and a completion date of May 19, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This federal contract award, valued at $1,203.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of May 14, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,141.82 firm-fixed-price contract is for the supply of 4565697906 CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide medical supplies and medications to various...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,931.01 firm fixed-price delivery order is for the supply of 4,566,481,699 units of CELLCEPT 500 MG TABLET 100S, with an ultimate completion date of November 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $39,863.84, is a Firm Fixed Price Delivery Order to provide 4,567,308,257 units of the drug CELLCEPT 500 MG TABLET 100S. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $85,073.04, is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a performance period through May 1, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 250 MG CAPSULE 100S, a pharmaceutical product, with a firm fixed price of $1,197.32 and a completion date of May 19, 2025. The contract is not set aside and was awarded on May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...